Stock 1228 CANBRIDGE PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus CANbridge Pharmaceuticals Inc.

Equities

1228

KYG1821D1097

Delayed Hong Kong S.E.
Other stock markets
 11:01:42 2024-04-24 pm EDT 		5-day change 1st Jan Change
0.47 HKD 0.00% Intraday chart for CANbridge Pharmaceuticals Inc. +46.88% -52.53%
Apr. 23 Canbridge Pharmaceuticals Shelves Glioblastoma Drug After Phase II Clinical Trials MT
Apr. 12 CANbridge Pharmaceuticals Inc. Announces Change of Principal Place of Business in Hong Kong, Effect from April 15, 2024 CI

Evolution of the average Target Price on CANbridge Pharmaceuticals Inc.

Price target over the last 5 years

History of analyst recommendation changes

6f75af3b4ca041f.TgXy7gEm1kdDCdlxR33Vuq-AwpM2fz8-HrDwic9fp0s.HGKYvEpU4zQheZsBdDvk4J7M9skGTl1rSfuk2I4rzDEqUYiPRHKCDyE4tg~cf0ab772c43e584f2fdb73e10fb77689

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
0.47 HKD
Average target price
7 HKD
Spread / Average Target
+1,389.36%
High Price Target
12.3 HKD
Spread / Highest target
+2,517.02%
Low Price Target
1.7 HKD
Spread / Lowest Target
+261.70%

Consensus detail

Consensus revision (last 18 months)

Ratings for CANbridge Pharmaceuticals Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. 1228 Stock
  4. Consensus CANbridge Pharmaceuticals Inc.